96 related articles for article (PubMed ID: 15521985)
1. Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia.
Brusgaard K; Kjeldsen AD; Poulsen L; Moss H; Vase P; Rasmussen K; Kruse TA; Hørder M
Clin Genet; 2004 Dec; 66(6):556-61. PubMed ID: 15521985
[TBL] [Abstract][Full Text] [Related]
2. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
[TBL] [Abstract][Full Text] [Related]
3. A novel endoglin mutation in hereditary hemorrhagic telangiectasia type 1: a case report.
Lu Y; Zhu Y; Shi L; Zhen H; Sun Z; Cheng L
Mol Med Rep; 2015 Jul; 12(1):510-2. PubMed ID: 25760803
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
[TBL] [Abstract][Full Text] [Related]
5. Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia.
Kjeldsen AD; Tørring PM; Nissen H; Andersen PE
Acta Neurol Scand; 2014 Mar; 129(3):192-7. PubMed ID: 23962120
[TBL] [Abstract][Full Text] [Related]
6. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
8. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia.
Lee NP; Matevski D; Dumitru D; Piovesan B; Rushlow D; Gallie BL
J Med Genet; 2011 May; 48(5):353-7. PubMed ID: 21415079
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function.
Mallet C; Lamribet K; Giraud S; Dupuis-Girod S; Feige JJ; Bailly S; Tillet E
Hum Mol Genet; 2015 Feb; 24(4):1142-54. PubMed ID: 25312062
[TBL] [Abstract][Full Text] [Related]
10. Hereditary hemorrhagic telangiectasia in Japanese patients.
Komiyama M; Ishiguro T; Yamada O; Morisaki H; Morisaki T
J Hum Genet; 2014 Jan; 59(1):37-41. PubMed ID: 24196379
[TBL] [Abstract][Full Text] [Related]
11. Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.
Wooderchak W; Gedge F; McDonald M; Krautscheid P; Wang X; Malkiewicz J; Bukjiok CJ; Lewis T; Bayrak-Toydemir P
Clin Genet; 2010 Nov; 78(5):484-9. PubMed ID: 20412114
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia.
Ruiz-Llorente L; Chiapparino E; Plumitallo S; Danesino C; Bayrak-Toydemir P; Pagella F; Manfredi G; Bernabeu C; Jovine L; Olivieri C
Gene; 2019 May; 696():33-39. PubMed ID: 30763665
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion/duplication analysis.
McDonald J; Damjanovich K; Millson A; Wooderchak W; Chibuk JM; Stevenson DA; Gedge F; Bayrak-Toydemir P
Clin Genet; 2011 Apr; 79(4):335-44. PubMed ID: 21158752
[TBL] [Abstract][Full Text] [Related]
14. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.
Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M
Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features and genetic screening of hereditary hemorrhagic telangiectasia].
Liu C; Lv YX; Yang XD; Huang YH; Luo Y; Yi Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):176-9. PubMed ID: 23568730
[TBL] [Abstract][Full Text] [Related]
16. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
[TBL] [Abstract][Full Text] [Related]
17. Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.
de Gussem EM; Edwards CP; Hosman AE; Westermann CJ; Snijder RJ; Faughnan ME; Mager JJ
Orphanet J Rare Dis; 2016 Apr; 11():46. PubMed ID: 27102204
[TBL] [Abstract][Full Text] [Related]
18. A novel ENG mutation causing impaired co-translational processing of endoglin associated with hereditary hemorrhagic telangiectasia.
Suzuki A; Nakashima D; Miyawaki Y; Fujita J; Maki A; Fujimori Y; Takagi A; Murate T; Teranishi M; Matsushita T; Saito H; Kojima T
Thromb Res; 2012 May; 129(5):e200-8. PubMed ID: 22385575
[TBL] [Abstract][Full Text] [Related]
19. [Early genetic diagnosis in patients with HHT induced severe nosebleed].
Ji L; Wang Z; Wang Q; Zhang J; Jia J; You S; Bai Y; Zhou X; Zhao S; Zhou Y; Zhang G; Wang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 27(5):241-5. PubMed ID: 23729109
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and genetic diagnosis in a hereditary hemorrhagic telangiectasia family].
Yi Y; Liu X; Wu B; Liu J; Ge S; Shi X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1017-1022. PubMed ID: 28989145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
